Related Experiment Videos
5'-Nucleotidase in lymphocytes from various clinical disorders
Leukemia Research
|January 1, 1983
Summary
5'-nucleotidase (5'-N) activity in lymphocytes is reduced in most leukemia and lymphoma types. Reduced 5'-N positivity was noted in chronic myeloid leukemia (CML) and acute myeloid leukemia (AML), with notable exceptions in chronic lymphocytic leukemia (CLL).
Area of Science:
- Hematology
- Biochemistry
- Cell Biology
Background:
- 5 -nucleotidase (5 -N) is an enzyme crucial for nucleotide metabolism.
- Its cytochemical localization in blood cells provides insights into cellular function and disease states.
Purpose of the Study:
- To investigate the activity and localization of 5 -nucleotidase (5 -N) in lymphocytes.
- To assess 5 -N activity in patients with various hematologic malignancies, including leukemia and lymphoma.
Main Methods:
- A modified Wachstein and Meisel technique was employed for cytochemical demonstration of 5 -N activity.
- Semiquantitative scoring of 5 -N positivity was performed on lymphocytes from normal donors and patients.
Main Results:
- 5 -N activity was primarily localized to the cell membrane of lymphocytes.
- Lymphocyte 5 -N scores were slightly reduced in chronic myeloid leukemia (CML) and acute myeloid leukemia (AML).
- Markedly reduced 5 -N activity was observed in most tested lymphoproliferative disorders, with supranormal activity found in some chronic lymphocytic leukemia (CLL) cases.
Conclusions:
- Lymphocyte 5 -N activity serves as a potential biomarker in hematologic malignancies.
- The enzyme's altered activity patterns may aid in differentiating between various types of leukemia and lymphoma.